Skip to main content
. 2015 Nov 4;6(3):339–346. doi: 10.1007/s13142-015-0353-9

Table 1.

Cardiovascular risk factor values, pre-treatment and post-treatment

Variables N Pre-treatment (M ± SD) Post-treatment (M ± SD) p a η p 2 Correlation of Δ with percent weight loss P b
Weight (kg) 401 97.67 ± 21.30 88.40 ± 19.41 <.001 .788
BMI (kg/m2) 377 35.10 ± 7.39 31.77 ± 6.86 <.001 .771
Glucose 359 99.28 ± 23.75 96.21 ± 18.17 .001 .032
 Women 287 97.76 ± 22.65 95.46 ± 18.07 −.037 .269
 Men 72 105.20 ± 26.97 99.18 ± 18.38 .233 .025
Triglyceridesc 358 120.37 ± 76.67 91.12 ± 52.84 <.001 .276
 Women 286 109.69 ± 58.28 90.85 ± 53.80 .262 <.001
 Men 72 162.40 ± 116.52 92.18 ± 49.21 .213 .037
Total cholesterolc 357 192.40 ± 36.12 171.75 ± 32.10 <.001 .323
 Women 286 194.64 ± 33.65 176.37 ± 29.92 .330 <.001
 Men 71 183.55 ± 43.69 153.15 ± 34.03 .279 .010
LDL cholesterol 358 118.21 ± 31.53 105.75 ± 28.06 <.001 .175
 Women 286 120.01 ± 29.70 108.35 ± 26.57 .217 <.001
 Men 72 110.78 ± 37.48 95.44 ± 31.47 .414 <.001
HDL cholesterol 358 50.21 ± 14.62 47.60 ± 13.75 .001 .033
 Women 286 52.79 ± 14.36 49.81 ± 13.60 .123 .019
 Men 72 40.04 ± 10.77 38.81 ± 10.49 −.055 .325

Note that significant changes and correlations are indicated by italicized p values. Percent weight loss was coded as a positive value, and risk factors were coded as negative values. Effect sizes indicated by partial eta-squared (η p 2); .04, .25, and .64 indicate weak, moderate, and strong effects, respectively [20]

aPre-treatment versus post-treatment, two-way repeated measure ANOVA

bPearson’s bivariate correlations, percent weight change with change in each cardiovascular risk factor, gender-specific

cRisk factors for which there were significant time by gender interactions